Amgen, Inc. (NASDAQ:AMGN) announced the submission of a New Drug Application (NDA) with the United States Food and Drug Administration (FDA) for etelcalcetide (formerly …
Many investors were on edge this weekend after the stock market plummeted on Thursday due to China’s faltering stock market and concerns that …
Recently, various executives have taken part in insider buying activity for the stocks of Cytori Therapeutics Inc (NASDAQ:CYTX), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Nuance Communications Inc.
Amgen, Inc. (NASDAQ:AMGN) and the Center for Social Sector Leadership at the University of California (UC), Berkeley’s Haas School of Business today announced a …
We evaluated 25 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising …
Nomura Holdings analyst Ian Somaiya came out with some commentary on Amgen Inc. (NASDAQ:AMGN) following an FDA panel recommendation for the company’s drug Repatha, …
The Sell-in-May-And-Go-Away season is upon us. For those who are unaware, the theory goes that markets tend to perform better when stocks are held …
There are many things that cause a stock to move: acquisition rumors, news stories (both positive and negative), earnings releases, analyst upgrades/downgrades, ETF-forced …
One of the more anticipated events of early 2015 played out on Friday – detailed results from an early study of Biogen Idec Inc's (NASDAQ:BIIB) experimental …
Just a day after Retrophin Inc. (NASDAQ:RTRX) announced a $100 million financing the U.
